Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 15001-15050 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06526793
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
PHASE2Recruiting
240 participants
Started: Nov 27, 2024 · Completed: Jun 14, 2029
3 conditions1 sponsor91 locations
NCT06650137
Evaluation of the Relevance of Diaphragmatic Stroke Ultrasound for the Etiological Diagnosis of Acute Respiratory Distress in an Emergency Department.
NARecruiting
100 participants
Started: Nov 27, 2024 · Completed: Nov 1, 2026
5 conditions1 sponsor2 locations
NCT06682754
Detection of Balance in the Elderly Under the Influence of Stress
NARecruiting
60 participants
Started: Nov 27, 2024 · Completed: Jul 31, 2026
1 condition3 sponsors1 location
NCT06733922
ELIOS - Investigational Biomarkers to Track Disease Modification in Active RRMS
PHASE4Recruiting
224 participants
Started: Nov 27, 2024 · Completed: Nov 30, 2027
1 condition1 sponsor9 locations
NCT06932224
This Study Aims to Measure the Effect of Acute Hospitalisation on the Physical and Cognitive Functioning of Older Orthopaedic Patients (Aged 65 or Above).
N/ARecruiting
70 participants
Started: Nov 27, 2024 · Completed: Oct 31, 2026
4 conditions1 sponsor1 location
NCT06303570
A Study to Evaluate the Efficacy and Safety of CBL-514 Compared to Placebo in Participants With Dercum's Disease Lipomas
PHASE2Recruiting
20 participants
Started: Nov 27, 2024 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT06159764
National Registry of Cardioneuroablation in Recurrent Reflex Syncope
N/ARecruiting
50 participants
Started: Nov 27, 2024 · Completed: Jan 31, 2026
3 conditions1 sponsor14 locations
NCT06767293
I-InTERACT Preterm Parenting
NARecruiting
90 participants
Started: Nov 27, 2024 · Completed: Sep 30, 2027
4 conditions1 sponsor1 location
NCT06497985
A Study of Tucidinostat in Combination With Sintilimab and Bevacizumab in MSS/pMMR Colorectal Cancer Patients
PHASE3Recruiting
430 participants
Started: Nov 27, 2024 · Completed: Sep 30, 2028
1 condition1 sponsor1 location
NCT06630416
Pemetrexed Response in Relation to Tumor Alterations of Gene Status for the Treatment of Patients With Metastatic Urothelial Bladder Cancer and Other Solid Tumors
PHASE2Recruiting
64 participants
Started: Nov 27, 2024 · Completed: May 10, 2030
3 conditions2 sponsors1 location
NCT06696287
The 6-minute Pegboard and Ring Test in Patients with Fibromyalgia Syndrome
N/ARecruiting
28 participants
Started: Nov 27, 2024 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT06474169
Assessment of T-cell Response and In-vitro Proof-of-concept of T-cell Engineering in Chronic ESKD Patients.
N/ARecruiting
100 participants
Started: Nov 27, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06687356
Study on the Application of Intraoperative Optical Coherence Tomography Technique in the Diagnosis and Treatment of Lens Diseases
NARecruiting
600 participants
Started: Nov 27, 2024 · Completed: Dec 31, 2029
1 condition1 sponsor2 locations
NCT06688851
Patient Specific Implants (PSIs) for the Decompression of Odontogenic Cysts
N/ARecruiting
20 participants
Started: Nov 26, 2024 · Completed: Jan 31, 2028
2 conditions1 sponsor1 location
NCT06560164
Restrictive Versus Liberal Thresholds for RBC Transfusion in ECMO
NARecruiting
526 participants
Started: Nov 26, 2024 · Completed: Oct 1, 2029
5 conditions2 sponsors12 locations
NCT06710795
AFFIX: Post-market Study of MaxTack™ Motorized Fixation Device in Subjects Undergoing Ventral Hernia Repair
NARecruiting
110 participants
Started: Nov 26, 2024 · Completed: Feb 15, 2027
1 condition1 sponsor3 locations
NCT06517212
Tirzepatide Weight Loss for MRD+ Early Breast Cancer
PHASE2Recruiting
48 participants
Started: Nov 26, 2024 · Completed: Dec 31, 2030
3 conditions1 sponsor1 location
NCT06507345
Postoperative Analgesia Intervention With Non-opioid Alternatives (PAIN-Alt) Trial - Breast Surgery
NARecruiting
540 participants
Started: Nov 26, 2024 · Completed: Feb 28, 2026
5 conditions2 sponsors1 location
NCT06236139
Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer
PHASE1/PHASE2Recruiting
48 participants
Started: Nov 26, 2024 · Completed: Mar 30, 2027
3 conditions2 sponsors1 location
NCT06134375
A Study of Tetrathiomolybdate (TM) Plus Capecitabine
PHASE1/PHASE2Recruiting
204 participants
Started: Nov 26, 2024 · Completed: Nov 26, 2034
2 conditions3 sponsors1 location
NCT05383911
Empowering Adolescents and Young Adults With Sickle Cell Disease as Partners in Treatment Decision Making (EMPOWER-AYA)
NARecruiting
68 participants
Started: Nov 26, 2024 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT06381713
Effect and Cost-utility of of High Intensity vs. Low Intensity Speech Intervention in Children With Cleft Palate
NARecruiting
70 participants
Started: Nov 26, 2024 · Completed: Dec 31, 2027
4 conditions2 sponsors1 location
NCT06543914
Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine
N/ARecruiting
1,000 participants
Started: Nov 26, 2024 · Completed: Feb 28, 2029
1 condition1 sponsor93 locations
NCT05066412
Prophylactic CD45RA-depleted DLI After Haploidentical Transplantation/RIC
PHASE1Recruiting
12 participants
Started: Nov 26, 2024 · Completed: Dec 2, 2026
2 conditions1 sponsor1 location
NCT05335096
An AI-based mHealth Intervention to Improve HIV Testing
NARecruiting
296 participants
Started: Nov 26, 2024 · Completed: Dec 15, 2025
1 condition3 sponsors1 location
NCT06611319
ENhanced Recovery and ABbreviated LEngth of Anticoagulation for Thromboprophylaxis After Primary Hip Arthroplasty
PHASE3Recruiting
2,932 participants
Started: Nov 26, 2024 · Completed: Jul 31, 2027
2 conditions1 sponsor6 locations
NCT06530030
Goal Attainment and Physical Activity in People With Hemophilia A
N/ARecruiting
35 participants
Started: Nov 26, 2024 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT06650592
Objective Assessment of Outcomes Following Immediate Lymphatic Reconstruction / LYMPHA
N/ARecruiting
90 participants
Started: Nov 26, 2024 · Completed: Oct 31, 2029
1 condition1 sponsor1 location
NCT06645678
Mezigdomide and Elranatamab for Relapsed And/or Refractory Multiple Myeloma
PHASE1/PHASE2Recruiting
75 participants
Started: Nov 26, 2024 · Completed: Oct 1, 2027
1 condition1 sponsor2 locations
NCT06665672
Effect of a Wrist-worn Device That Produces a Small Vibration on Sleep and Performance That Can Occur During and After Night Shift Work
NARecruiting
24 participants
Started: Nov 26, 2024 · Completed: Mar 31, 2026
2 conditions1 sponsor1 location
NCT06660368
BCL2i CLAG-M in R/R Acute Myeloid Leukemia
PHASE2Recruiting
52 participants
Started: Nov 26, 2024 · Completed: Nov 30, 2027
1 condition2 sponsors2 locations
NCT06585488
A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification
PHASE1Recruiting
514 participants
Started: Nov 26, 2024 · Completed: Dec 31, 2026
7 conditions1 sponsor17 locations
NCT06767917
A Post-Market Clinical Follow-Up on Safety and Performance of the Ophthalmic Viscoelastic Devices Eyefill SC and Eyefill MB
NARecruiting
150 participants
Started: Nov 26, 2024 · Completed: Jan 31, 2026
1 condition1 sponsor2 locations
NCT06755866
DCE-MRI Based on 4D Free Breathing for Predicting Preoperative Neoadjuvant Chemoradiotherapy for Esophageal Cancer
NARecruiting
135 participants
Started: Nov 26, 2024 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT06701630
Italian Adaptation and Validation of Functional and Behavioural Scales for Subjective Cognitive Decline, Mild Cognitive Impairment and Mild Dementia.
N/ARecruiting
390 participants
Started: Nov 26, 2024 · Completed: Nov 30, 2026
4 conditions1 sponsor1 location
NCT06869863
Study of Tolerability, Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of the Medicinal Product MediReg®
PHASE1/PHASE2Recruiting
80 participants
Started: Nov 26, 2024 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location
NCT06693895
A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of Age
PHASE3Recruiting
750 participants
Started: Nov 26, 2024 · Completed: Nov 23, 2026
1 condition1 sponsor1 location
NCT06986603
Glucagon Dose-Response in Patients With Post-Bariatric Hypoglycemia
PHASE4Recruiting
28 participants
Started: Nov 26, 2024 · Completed: Sep 1, 2026
3 conditions4 sponsors2 locations
NCT06737107
Multicenter Analysis of Different Approaches in Segmentectomies in Early-stage Lung Cancer
N/ARecruiting
472 participants
Started: Nov 26, 2024 · Completed: May 31, 2026
2 conditions4 sponsors4 locations
NCT05879146
Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical Study
PHASE2Recruiting
40 participants
Started: Nov 26, 2024 · Completed: Jan 31, 2028
1 condition2 sponsors1 location
NCT06498960
Evaluation of the Safety and Effectiveness of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus
NARecruiting
230 participants
Started: Nov 26, 2024 · Completed: Jan 1, 2031
1 condition1 sponsor28 locations
NCT06690346
Systematic Oral Education for Prevention of Oral-related Complications Caused by Radiotherapy for Head and Neck Cancer
PHASE2Recruiting
150 participants
Started: Nov 26, 2024 · Completed: Nov 26, 2026
2 conditions2 sponsors1 location
NCT06607003
Induced Blood-Stage Malaria in Healthy Malaria-Naive Adults to Assess the Safety and Infectivity of Plasmodium Vivax Challenge Agent and Evaluate Transmission in Mosquito Feeding Assays
PHASE1Recruiting
200 participants
Started: Nov 26, 2024 · Completed: Jul 15, 2026
1 condition1 sponsor1 location
NCT06664151
A Phase 0 Window of Opportunity Trial of Intratumoral Seasonal Influenza Immunization in Cutaneous Squamous Cell Carcinoma (CSCC) Patients Awaiting Curative Excision
EARLY_PHASE1Recruiting
25 participants
Started: Nov 26, 2024 · Completed: Aug 30, 2026
3 conditions1 sponsor2 locations
NCT06685718
A Study Investigating BG-60366 in Adults With Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer
PHASE1Recruiting
93 participants
Started: Nov 26, 2024 · Completed: Apr 30, 2028
6 conditions1 sponsor42 locations
NCT06366282
Pediatric and Caregiver Traumatic Stress Intervention (PACTS)
NARecruiting
24 participants
Started: Nov 26, 2024 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT06085625
A Randomized Control Trial for Patient Reported Outcomes and Safety in Outpatient Thyroid Lobectomy
PHASE2Recruiting
224 participants
Started: Nov 26, 2024 · Completed: Nov 1, 2027
1 condition1 sponsor1 location
NCT05763537
Understanding the Role of Doulas in Supporting People With PMADs
NARecruiting
75 participants
Started: Nov 26, 2024 · Completed: Dec 28, 2026
10 conditions1 sponsor1 location
NCT06395467
Integrated Treatment for Enhancing Growth in Recovery During Adolescence
NARecruiting
294 participants
Started: Nov 26, 2024 · Completed: May 31, 2028
2 conditions2 sponsors2 locations
NCT07155772
Feasibility Study on a Prehospital Extracorporeal CardioPulmonary Resuscitation in the Pavia's Province.
NARecruiting
20 participants
Started: Nov 26, 2024 · Completed: Oct 31, 2025
1 condition1 sponsor1 location